•
Mar 31, 2018

Corcept Therapeutics Q1 2018 Earnings Report

Total Revenue
$57.7M
Previous year: $27.6M
+108.9%
EPS
$0.19
Previous year: $0.06
+216.7%
Gross Profit
$56.5M
Previous year: $27M
+109.6%
Cash and Equivalents
$33.1M
Previous year: $38M
-12.8%
Free Cash Flow
$34.4M
Total Assets
$243M
Previous year: $75.3M
+222.5%

Corcept Therapeutics

Corcept Therapeutics